Unknown

Dataset Information

0

Novel approaches to treating Clostridium difficile-associated colitis.


ABSTRACT: Clostridium difficile is being recognized as a growing threat to many health-care systems. Epidemiology data shows that infection rates are soaring and the disease burden is increasing. Despite the efficacy of standard treatments, it is becoming evident that novel therapeutics will be required to tackle this disease. These new treatments aim to enhance the intestinal microbial barrier, activate the immune system and neutralize the toxins that mediate this disease. Many of these therapies are still in the beginning stages of investigation, however, in the next few years, more clinical data will become available to help implement many of these exciting new therapeutic approaches.

SUBMITTER: Padua D 

PROVIDER: S-EPMC5979265 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel approaches to treating Clostridium difficile-associated colitis.

Padua David D   Pothoulakis Charalabos C  

Expert review of gastroenterology & hepatology 20151207 2


Clostridium difficile is being recognized as a growing threat to many health-care systems. Epidemiology data shows that infection rates are soaring and the disease burden is increasing. Despite the efficacy of standard treatments, it is becoming evident that novel therapeutics will be required to tackle this disease. These new treatments aim to enhance the intestinal microbial barrier, activate the immune system and neutralize the toxins that mediate this disease. Many of these therapies are sti  ...[more]

Similar Datasets

| S-EPMC5899687 | biostudies-literature
| S-EPMC4442717 | biostudies-other
| S-EPMC1891485 | biostudies-other
| S-EPMC3749013 | biostudies-literature
| S-EPMC6025901 | biostudies-literature
| S-EPMC3602426 | biostudies-literature
| S-EPMC3755009 | biostudies-literature
| S-EPMC3737259 | biostudies-literature
| S-EPMC4222064 | biostudies-other
| S-EPMC6492486 | biostudies-literature